 |
 |

Comparative Evolution of Alzheimer Disease, Vascular Dementia, and Mixed Dementia
John V. Bowler, MB, MD, MRCP;
Michael Eliasziw, PhD;
Runa Steenhuis, PhD;
David G. Munoz, MD, FRCPC;
Rick Fry, MSc;
Harold Merskey, DM, FRCPC;
Vladimir C. Hachinski, MD, FRCPC, DScMed
Arch Neurol. 1997;54(6):697-703.
Abstract
Objective To compare the evolution of Alzheimer disease (AD), vascular dementia (VaD), and mixed dementia by cognitive domain.
Setting The University of Western Ontario Dementia Study, which is a registry of cases of dementia seen for secondary and tertiary assessment in a university memory disorders clinic with extensive follow-up data and histopathological confirmation of clinical diagnoses.
Patients One hundred twenty-nine patients with definite or probable AD, 12 patients with definite or probable VaD, and 36 patients with definite or probable mixed dementia.
Methods Patients were grouped as having an early, moderate, or advanced stage of disease according to the extended scale for dementia (ESD). The ESD was subdivided into cognitive domains, and the domain scores were compared for each stage of disease by diagnostic category with the use of a 2-way analysis of variance with repeated measures.
Results As expected, the scores in all domains decreased significantly with increasing severity. There was a significant difference in the decline in memory among the diagnostic groups (P=.02) that was mostly attributable to the difference between AD and mixed dementia (P=.03), with the difference between AD and VaD only approaching significance (P=.06). There was a similar finding for praxis. The interaction between diagnosis (AD and VaD) and severity was significant only for memory (P=.02), showing a less severe memory deficit at onset but a proportionately more rapid progression in VaD and arithmetic ability (AD and mixed dementia [P=.03]).
Conclusions Alzheimer disease, VaD, and mixed dementia evolve similarly as assessed using cognitive domains obtained by subdivision of the ESD in a patient population derived from a memory clinic and by analyzing VaD as a single entity. Only memory impairment evolves differently between AD and VaD, with this depending on the severity. Memory is more severely impaired in the early stage of AD; however, with increasing severity of dementia, memory impairment in VaD accelerates and catches up with AD at the level of moderate impairment. The differences between AD and mixed dementia are greater than those between mixed dementia and VaD, suggesting an important role for the ischemic component of mixed dementia. Simple neuropsychological tools (eg, the ESD) may be incapable of distinguishing between AD and VaD, and more focused instruments may be required. Inherent bias in case selection may prevent extrapolation of these results to VaD in general, but the neuropsychological criteria for VaD may need to vary, depending on the severity.
Author Affiliations
From the Departments of Clinical Neurological Sciences (Drs Bowler, Eliasziw, and Hachinski and Mr Fry), Epidemiology and Biostatistics (Drs Eliasziw and Hachinski), Psychiatry (Dr Merskey), and Pathology (Dr Munoz) and the J. P. Robarts Research Institute (Drs Bowler, Eliasziw, Munoz, and Hachinski and Mr Fry), University of Western Ontario, London; and Psychological Services, University Hospital, London, Ontario (Dr Steenhuis). Dr Bowler was a fellow with the Heart and Stroke Foundation of Ontario, London.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease
Bruandet et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:133-139.
ABSTRACT
| FULL TEXT
Chapter 34 Neuropsychological disorders, dementia, and behavioural neurology
Rossor
Brain's Diseases of the Nervous System 2009;12:med-9780198569381-chapter-med-9780198569381-chapter.
ABSTRACT
| FULL TEXT
Galantamine treatment of vascular dementia: A randomized trial
Auchus et al.
Neurology 2007;69:448-458.
ABSTRACT
| FULL TEXT
Challenges in Systematic Reviews That Evaluate Drug Efficacy or Effectiveness
Santaguida et al.
ANN INTERN MED 2005;142:1066-1072.
ABSTRACT
| FULL TEXT
Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia
Graham et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:61-71.
ABSTRACT
| FULL TEXT
Alzheimer Disease as a Vascular Disorder: Nosological Evidence
de la Torre
Stroke 2002;33:1152-1162.
ABSTRACT
| FULL TEXT
Small Concomitant Cerebrovascular Lesions Are Not Important for Cognitive Decline in Severe Alzheimer Disease
Jellinger and Thal
Arch Neurol 2001;58:520-521.
FULL TEXT
Small Concomitant Vascular Lesions Do Not Influence Rates of Cognitive Decline in Patients With Alzheimer Disease
Lee et al.
Arch Neurol 2000;57:1474-1479.
ABSTRACT
| FULL TEXT
Prevalence and outcomes of vascular cognitive impairment
Rockwood et al.
Neurology 2000;54:447-447.
ABSTRACT
| FULL TEXT
Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease
Bowler et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:18-24.
ABSTRACT
| FULL TEXT
|